CS275231B2 - Medicine bottle - Google Patents

Medicine bottle

Info

Publication number
CS275231B2
CS275231B2 CS895552A CS555289A CS275231B2 CS 275231 B2 CS275231 B2 CS 275231B2 CS 895552 A CS895552 A CS 895552A CS 555289 A CS555289 A CS 555289A CS 275231 B2 CS275231 B2 CS 275231B2
Authority
CS
Czechoslovakia
Prior art keywords
per
ointment base
antiphlogistics
medicine bottle
medcamentous
Prior art date
Application number
CS895552A
Other languages
Czech (cs)
English (en)
Inventor
Jitka Mudr Csc Cejkova
Jiri Ing Csc Vacik
Zdenek Prof Mudr Drsc Lojda
Original Assignee
Ustav Makormolekularni Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ustav Makormolekularni Chemie filed Critical Ustav Makormolekularni Chemie
Priority to CS895552A priority Critical patent/CS275231B2/cs
Priority to CA002026166A priority patent/CA2026166A1/fr
Priority to EP90310516A priority patent/EP0420600B1/fr
Priority to US07/588,322 priority patent/US5244673A/en
Priority to AU63170/90A priority patent/AU6317090A/en
Priority to AT90310516T priority patent/ATE151640T1/de
Priority to DE69030476T priority patent/DE69030476T2/de
Publication of CS275231B2 publication Critical patent/CS275231B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Centrifugal Separators (AREA)
  • Saccharide Compounds (AREA)
CS895552A 1989-09-29 1989-09-29 Medicine bottle CS275231B2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CS895552A CS275231B2 (en) 1989-09-29 1989-09-29 Medicine bottle
CA002026166A CA2026166A1 (fr) 1989-09-29 1990-09-25 Forme medicamenteuse
EP90310516A EP0420600B1 (fr) 1989-09-29 1990-09-26 Utilisation des inhibiteurs des protéases comme agents anti-exudatifs, antiphlogistiques et antimicrobiens
US07/588,322 US5244673A (en) 1989-09-29 1990-09-26 Medicamentous form for use as an ophthalmologic, otolaryngologic, or dermatologic drug
AU63170/90A AU6317090A (en) 1989-09-29 1990-09-26 Medicamentous form
AT90310516T ATE151640T1 (de) 1989-09-29 1990-09-26 Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel
DE69030476T DE69030476T2 (de) 1989-09-29 1990-09-26 Verwendung von Protease-Inhibitoren als antiexudative, antiphlogistische und antimikrobielle Mittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS895552A CS275231B2 (en) 1989-09-29 1989-09-29 Medicine bottle

Publications (1)

Publication Number Publication Date
CS275231B2 true CS275231B2 (en) 1992-02-19

Family

ID=5400638

Family Applications (1)

Application Number Title Priority Date Filing Date
CS895552A CS275231B2 (en) 1989-09-29 1989-09-29 Medicine bottle

Country Status (7)

Country Link
US (1) US5244673A (fr)
EP (1) EP0420600B1 (fr)
AT (1) ATE151640T1 (fr)
AU (1) AU6317090A (fr)
CA (1) CA2026166A1 (fr)
CS (1) CS275231B2 (fr)
DE (1) DE69030476T2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
DE59209963D1 (de) * 1991-09-13 2002-08-14 Pentapharm Ag Basel Proteinfraktion zur kosmetischen und dermatologischen Pflege der Haut
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
GB2271507A (en) * 1992-09-04 1994-04-20 Summit Technology Ireland Bv Compositions containing plasmin activity inhibitors
IL109705A (en) * 1993-06-17 1998-07-15 Allergan Inc Enzyme compositions and methods for contact lens cleaning
US5783532A (en) * 1993-06-17 1998-07-21 Allergan Enzyme compositions and methods for contact lens cleaning
WO1995009905A1 (fr) * 1993-10-06 1995-04-13 Allergan, Inc. Compositions et procedes pour inhiber et reduire le depot de lysozymes sur des lentilles de contact hydrophiles
US5688781A (en) * 1994-08-19 1997-11-18 Bristol-Myers Squibb Company Method for treating vascular leak syndrome
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
CA2289618A1 (fr) * 1997-05-14 1998-11-19 Shin-Ichi Yasueda Preparations a base de suspensions aqueuses possedant d'excellentes proprietes de redispersion
US6914057B1 (en) 1998-09-28 2005-07-05 The Research Foundation Of State University Of New York Inhibitor of cataract formation
EP1124558A4 (fr) * 1998-09-28 2004-10-27 Res Foundation Ofstate Univers Nouvel inhibiteur de formation de cataracte
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
KR100450864B1 (ko) * 2001-11-23 2004-10-01 한국과학기술연구원 Ｒｎａ 표적 분자에 대해 특이성이 향상된네오마이신-클로람페니콜 헤테로 이합체 및 그의 제조방법
DE10227938B4 (de) 2002-06-21 2006-07-20 Heraeus Kulzer Gmbh Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung
DE60328909D1 (de) * 2002-11-20 2009-10-01 Arriva Prometic Inc Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin
EP1740168A2 (fr) * 2004-04-21 2007-01-10 Advanced Ocular Systems Limited Antiprostaglandines pour le traitement de pathologies oculaires
US20070248646A1 (en) * 2006-02-16 2007-10-25 Ali Hafezi-Moghadam Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
AR061487A1 (es) * 2006-06-15 2008-08-27 Serenex Inc Una composicion farmaceutica en forma de comprimido multicapa de tetraciclina
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
EP3132033B1 (fr) 2014-04-17 2019-10-30 Synthetic Biologics, Inc. Bêta-lactamases présentant des propriétés améliorées pour traitement
JP6803328B2 (ja) 2014-08-28 2021-01-06 シンセティック バイオロジクス，インコーポレイテッド 大腸菌ベースでのベータラクタマーゼ生産
JP6672277B2 (ja) 2014-10-08 2020-04-01 シンセティック・バイオロジクス・インコーポレイテッド ベータラクタマーゼ製剤およびその使用
WO2016105498A1 (fr) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Méthodes et compositions pour inhiber ou prévenir les effets néfastes des antibiotiques oraux
CN107530406B (zh) 2015-02-23 2021-10-22 合成生物制品有限公司 用于保护肠微生物群系的与抗生素一起使用的碳青霉烯酶
AU2016229976B2 (en) 2015-03-06 2021-11-11 Theriva Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
WO2017146603A1 (fr) * 2016-02-24 2017-08-31 Arcasiu Nicolae Composition pharmaceutique pour le traitement de brûlures, utilisation, et méthode de traitement
WO2018075810A1 (fr) * 2016-10-18 2018-04-26 Somahultion, Llc Compositions dermatologiques pour fournir des nutriments à la peau et procédés associés
US10328154B2 (en) * 2017-10-27 2019-06-25 BUFFERAD Illinois Inc. Topical compositions for improved delivery of active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390541A (en) * 1971-04-14 1975-04-16 Otsuka Kagaku Yakuhin Anti-inflammatory compositions
SE375007B (fr) * 1972-11-30 1975-04-07 Pharmacia Ab
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.

Also Published As

Publication number Publication date
DE69030476T2 (de) 1997-11-27
CA2026166A1 (fr) 1991-03-30
EP0420600B1 (fr) 1997-04-16
EP0420600A2 (fr) 1991-04-03
DE69030476D1 (de) 1997-05-22
US5244673A (en) 1993-09-14
EP0420600A3 (en) 1992-11-19
ATE151640T1 (de) 1997-05-15
AU6317090A (en) 1991-04-11

Similar Documents

Publication Publication Date Title
CS275231B2 (en) Medicine bottle
TW234691B (fr)
TW337488B (en) A carbohydrate glass matrix for the sustained release of a therapeutic agent
GR3034921T3 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
WO1992019104A3 (fr) Compositions a base d'acides gras utilisees pour eliminer les infections existant dans des plantes
AU5094985A (en) Wound healing agents
AU3351293A (en) Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
GB2276819B (en) Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
CA2136331A1 (fr) Nouveaux usages pharmaceutiques d'enzymes de krill
MY106271A (en) Cyclosporin ophthalmic compositions.
CA2159449A1 (fr) Composition a base de pdgf et de vitamine d stimulant la croissance d'osteoblastes
AU2689292A (en) Cyclohexaneacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
WO1994026113A3 (fr) Formulations destinees au traitement cutane par deversement, contenant une substance polymere, des glycols et des glycerides
GR3033728T3 (en) Tablets containing thioctic acid with a specified size.
AU1944997A (en) Angiogenic inhibitor containing tissue factor pathway inhibitor
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
AU5187493A (en) Use of certain methanebisphosphonic acid derivatives in fracture healing
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
PL307051A1 (en) Ophthalmic agent for local administration containing (s)-thymol semihydrate
GB9505082D0 (en) Medicament
AU6131790A (en) Use of iodopropargyl esters of a-amino acid derivatives as antimicrobial agents
AU7037591A (en) Stabilization of t-pa pro
EP0477143A3 (en) Pharmaceutical composition having a cicatrising effect
UA30359A (uk) Спосіб лікування гнійних ран

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20010929